• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023)
23 March 2017

Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023)

Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023) that belongs to the RIS3CAT community “Technologies applied to health”.


The objective of this project is to perform preclinical and clinical studies on the application of nanoformulated epithelial growth factor in venous ulcers.


This project has been cofounded 50% by the European Regional Development Funds from the European Union within the framework of the operative FEDER program in Catalonia 2014-2020.

Related
news

Nanomol Technologies is part of the new Horizon 2020 Framework Programme project “Smart-4-Fabry” (Smart multifunctional GLA-nanoformulation for Fabry disease) 12 January 2017

Nanomol Technologies is part of the new Horizon 2020 Framework Programme project “Smart-4-Fabry” (Smart multifunctional GLA-nanoformulation for Fabry disease)
Networking and Beers 23 May 2022

Networking and Beers
SANTI SALA, CEO AND COFOUNDER OF NANOMOL TECHNOLOGIES, WILL PARTICIPATE ON JUNE 29 IN A TECH TRANSFER FORUM 23 June 2021

SANTI SALA, CEO AND COFOUNDER OF NANOMOL TECHNOLOGIES, WILL PARTICIPATE ON JUNE 29 IN A TECH TRANSFER FORUM

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki